Navigation Links
NFL Docs Urge More Caution With Key Pain Med
Date:9/11/2012

TUESDAY, Sept. 11 (HealthDay News) -- New recommendations by NFL team doctors suggest increased caution in the use of the pain reliever ketorolac tromethamine (Toradol) by professional football players.

Ketorolac is a nonsteroidal anti-inflammatory drug (NSAID). Athletes have long taken NSAIDs for pain prevention and relief before, during and after competition. But the recommendations by a task force developed through the NFL Team Physicians Society suggests more careful use of ketorolac.

The recommendations are published in the September/October issue of the journal Sports Health: A Multidisciplinary Approach.

"Ketorolac has been used most frequently as an analgesic pain reliever following strains, sprains and overuse injuries. Our recommendations on its use in NFL players hopefully will help minimize the risk of complications and allow for all parties involved in the health of athletes to better understand, how, when and why to use ketorolac more effectively and safely," lead author Dr. Matthew Matava, president-elect of the NFL Team Physicians Society, said in a journal news release.

The recommendations on ketorolac indicate:

  • It should be given only under the direct supervision and order of a team physician.
  • It should not be used before competition as a means of reducing anticipated pain.
  • It should only be used in players diagnosed with an injury or condition who are listed on the teams' latest injury report.
  • It should be given in the lowest effective therapeutic dose and for no more than five days.
  • It should be given by mouth under typical circumstances.
  • It should not be given by intramuscular and intravenous injection except following an acute, game-related injury where significant bleeding is not expected.
  • It should not be taken concurrently with other NSAIDs.

More information

The U.S. Food and Drug Administration offers a guide to the safe use of pain medicine.

-- Robert Preidt

SOURCE: Sports Health: A Multidisciplinary Approach, news release, Aug. 28, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Precautions for tick-borne disease extend beyond Lyme
2. Use Caution When Exercising in Hot Weather
3. Supplements and cancer prevention: A cautionary tale
4. Penn study cautions use of drugs to block niacin flush
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
NFL Docs Urge More Caution With Key Pain Med
(Date:12/7/2016)... (PRWEB) , ... December 07, 2016 , ... A quote ... an outpouring of comments on social media that offer a rare glimpse into the ... leading ADHD authority and New York Times bestselling author, has described people with ADHD ...
(Date:12/7/2016)... , ... December 07, 2016 , ... ... connectors, is now promoting to the US market its advanced highly customizable contact ... and ODU TURNTAC®. These advanced technologies are ideal for a wide range ...
(Date:12/7/2016)... ... 07, 2016 , ... One of two inventors from Glen Burnie, Md., has ... for her. "This is why the co-inventor and I have designed a new and ... created a prototype of the patent-pending AV-AIR, a device that serves as an alternative ...
(Date:12/7/2016)... ... December 07, 2016 , ... Sharon Kleyne, host of the nationally ... Your Health on Voice of America, declared on her radio program in November 2016 ... fact that when these bullies attack leaders in corporate America, they are trying to ...
(Date:12/7/2016)... ... December 07, 2016 , ... Texas Premier Locksmith , ... out by unethical locksmith companies and is urging Search Engines to improve verification ... Texas Premier Locksmith, these fraudulent locksmith services take advantage of consumers locked out ...
Breaking Medicine News(10 mins):
(Date:12/7/2016)... YORK , Dec. 7, 2016 ... report on pulmonary drugs studies the current as ... The stakeholders of this report include companies and ... various pulmonary/respiratory drugs and/or drug-device combinations as well ... This report comprises an elaborate executive summary along ...
(Date:12/7/2016)... , December 7, 2016 ... "Clinical Trial Management System (CTMS) Market, by Components ... (Enterprises, Site), End-users (Pharmaceutical and Biotechnology Companies, Clinical ... Growth, Share, Size and Forecast to 2022", published ... management system (CTMS) market is expected to grow ...
(Date:12/7/2016)... Corporate Whistleblower Center is urging a physician ... 866-714-6466 if they possess proof a pharmaceutical company is bribing doctors ... the innocent patients frequently being the victims, these types of schemes ... Medicare recipients or the elderly. Photo ... ...
Breaking Medicine Technology: